Voyager Therapeutics, Inc.
VYGR
$3.26
-$0.15-4.27%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 12.40% | -1.86% | 1.67% | 16.45% | -7.61% |
| Total Depreciation and Amortization | -2.58% | -11.15% | 12.55% | -12.49% | 5.03% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.96% | -21.39% | 6.83% | -11.15% | 15.79% |
| Change in Net Operating Assets | 40.13% | -19.57% | -0.91% | -48.03% | 53.53% |
| Cash from Operations | 22.67% | -10.43% | 2.53% | 6.65% | 12.23% |
| Capital Expenditure | 100.00% | 97.76% | -202.42% | 81.27% | -67.93% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 89.66% | -83.11% | 36.91% | 1,055.20% | -92.74% |
| Cash from Investing | 89.99% | -82.92% | 35.93% | 1,704.86% | -95.31% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -12.79% | 2,350.00% | 60.00% | -83.43% | 525.61% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -12.79% | 2,350.00% | 60.00% | -83.43% | 525.61% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 65.68% | -227.11% | 340.69% | 112.74% | -1,009.53% |